MOSAIC CO: management transactions · United States · SEC (Form 4)

About MOSAIC CO

The Mosaic Company (NYSE: MOS) is a leading global crop-nutrients and agricultural inputs company headquartered in Tampa, Florida, United States. It was formed in 2004 through the combination of IMC Global and Cargill’s crop nutrition division, and today it is best understood as a cyclical, resource-backed fertiliser producer with significant exposure to global farm economics, potash and phosphate pricing, and agricultural credit conditions in North America and Brazil. Mosaic’s business model is built around three core activities: mining and processing phosphate and potash, marketing those nutrients to agricultural customers, and expanding into value-added biological solutions through its Mosaic Biosciences platform. The company describes itself as one of the world’s leading producers and marketers of concentrated phosphate and potash crop nutrients, and it also supplies biological products intended to help farmers improve nutrient-use efficiency and crop performance. Its customer base includes ag retailers, crop advisers, and growers across more than 40 countries. Geographically, Mosaic has a broad operating footprint. In North America, it mines phosphate in Central Florida and potash in Saskatchewan and New Mexico, while also operating phosphate concentrate sites in Louisiana and Florida. In South America, Mosaic Fertilizantes operates across Brazil, Paraguay and Peru, supported by commercial, production, port and storage assets, including significant blending capacity in Brazil. This geographic diversification gives the company a meaningful logistics and market-access advantage, especially when demand conditions shift between regions. From a competitive standpoint, Mosaic holds a strong position in concentrated phosphate and potash, two inputs that remain essential to global food production. Its scale, resource base, distribution network and access to multiple end markets are important barriers to entry. The company also sells performance fertilizers, crop-nutrition products and feed ingredients, which broaden its portfolio beyond pure commodity exposure. Mosaic Biosciences adds a more innovation-oriented layer to the story, with biological complements designed to support better agronomy and higher yields. Historically, the company has evolved through acquisitions, capacity investments and portfolio optimisation. Recent milestones include the launch of Mosaic Biosciences in 2023, the continued ramp-up of strategic assets, and ongoing efforts to strengthen the Brazilian business. In its latest disclosures, Mosaic reported improved phosphate production trends and strong potash performance, while also noting a weak North American fourth quarter in late 2025 due to softer grower demand. Management has indicated a more constructive outlook for 2026, supported by nutrient replenishment needs, tighter phosphate markets, balanced potash conditions, and export restrictions in China that may support global pricing. Mosaic also completed select Brazilian asset sales and benefited from the U.S. government’s decision to add phosphate and potash to the Critical Minerals List, underscoring the strategic importance of its products.